Oxana Beskrovnaya, Chief Scientific Officer at Dyne Therapeutics, Inc. (DYN), sold 2,598 shares at $13.95 ($36K) on 2025-02-18, disclosed to the SEC on 2025-02-25.
Scheduled sale ($36k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| DYN | SELL | 2024-12-11 | $131K | — | Filing → |
| DYN | SELL | 2024-11-18 | $161K | — | Filing → |
| DYN | SELL | 2024-09-19 | $162K | — | Filing → |